New blood test useful to detect people at risk of developing Alzheimer’s disease

Heidelberg, 6 April 2018 − There is, as yet, no cure for Alzheimer’s disease. It is often argued that progress in drug research has been hampered by the fact that the disease can only be diagnosed when it is too late for an effective intervention. Alzheimer’s disease is thought to begin long before patients show typical symptoms. Scientists have now developed a blood test for Alzheimer’s disease that can detect early indicators of the disease before the first symptoms appear in patients. The blood test would thus offer an opportunity to identify those at risk and may thereby open the door to new avenues in drug discovery. The research is published today in EMBO Molecular Medicine. (Mehr in: Pressemitteilungen – idw – Informationsdienst Wissenschaft)